Tiotropio mejora la función pulmonar y el control del asma en pacientes con asma leve, moderada y severa
Tiotropio mejora la función pulmonar y el control del asma en pacientes con asma leve, moderada y severa
Contenido principal del artículo
Descargas
Detalles del artículo
Referencias (VER)
Popescu FD. The pharmacological rationale for the use of inhaled tiotropium in asthma. Pneumologia. 2015;64:52-3.
Novelli F, Costa F, Latorre M, Malagrinò L, Celi A, Vagaggini B. Tiotropium: a new therapeutic option in asthma. Monaldi Arch Chest Dis. 2013;79:109-15.
From the Global Strategy for Asthma Management and Prevention, Global Initiative for Asthma (GINA) 2015. Disponible en: http://www.ginasthma.org/. Fecha de acceso: 10/09/14.
Kew KM, Evans DJ, Allison DE, Boyter AC. Long-acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus addition of long-acting beta2-agonists (LABA) for adults with asthma.
Cochrane Database Syst Rev. 2015;6:CD011438.
Evans DJ, Kew KM, Anderson DE, Boyter AC. Long-acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus higher dose ICS for adults with asthma. Cochrane Database Syst Rev.
;7:CD011437.
Anderson DE, Kew KM, Boyter AC. Long-acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus the same dose of ICS alone for adults with asthma. Cochrane Database Syst Rev.
;8:CD011397.